These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 21375358

  • 1. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
    Armstrong EP, Malone DC, McCarberg B, Panarites CJ, Pham SV.
    Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.
    Dakin H, Nuijten M, Liedgens H, Nautrup BP.
    Clin Ther; 2007 Jul; 29(7):1491-507. PubMed ID: 17825701
    [Abstract] [Full Text] [Related]

  • 3. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
    Kirson NY, Ivanova JI, Birnbaum HG, Wei R, Kantor E, Puenpatom RA, Ben-Joseph RH, Summers KH.
    J Med Econ; 2010 Jul; 13(3):482-91. PubMed ID: 20684669
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
    Liedgens H, Hertel N, Gabriel A, Nuijten M, Dakin H, Mitchell S, Nautrup BP.
    Clin Drug Investig; 2008 Jul; 28(9):583-601. PubMed ID: 18666805
    [Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Ritchie M, Liedgens H, Nuijten M.
    Clin Drug Investig; 2010 Jul; 30(2):71-87. PubMed ID: 20067326
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C.
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [Abstract] [Full Text] [Related]

  • 7. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.
    O'Connor AB, Noyes K, Holloway RG.
    J Am Geriatr Soc; 2007 Aug; 55(8):1176-84. PubMed ID: 17661955
    [Abstract] [Full Text] [Related]

  • 8. Review of current guidelines on the care of postherpetic neuralgia.
    Argoff CE.
    Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
    [Abstract] [Full Text] [Related]

  • 9. Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland.
    Mankowski C, Patel S, Trueman D, Bentley A, Poole C.
    PLoS One; 2016 Sep; 11(3):e0150973. PubMed ID: 26983018
    [Abstract] [Full Text] [Related]

  • 10. Cost-utility of pregabalin as add-on to usual care versus usual care alone in the management of peripheral neuropathic pain in Belgium.
    Chevalier P, Lamotte M, Van Campenhout H, Eyckerman R, Annemans L.
    J Med Econ; 2013 Sep; 16(5):596-605. PubMed ID: 23409950
    [Abstract] [Full Text] [Related]

  • 11. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M, Sadosky A, Tai KS, Stacey B.
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    Wu EQ, Birnbaum HG, Mareva MN, Le TK, Robinson RL, Rosen A, Gelwicks S.
    J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
    [Abstract] [Full Text] [Related]

  • 13. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
    Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J.
    Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364
    [Abstract] [Full Text] [Related]

  • 14. Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.
    Carlos F, Ramírez-Gámez J, Dueñas H, Galindo-Suárez RM, Ramos E.
    J Med Econ; 2012 May; 15(2):233-44. PubMed ID: 22082033
    [Abstract] [Full Text] [Related]

  • 15. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E, Richards S, Bowrin K, Watson P, Lloyd A, Sadosky A, Zlateva G.
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.
    Arreola Ornelas H, Rosado Buzzo A, García L, Dorantes Aguilar J, Contreras Hernández I, Mould Quevedo JF.
    Reumatol Clin; 2012 Apr; 8(3):120-7. PubMed ID: 22386298
    [Abstract] [Full Text] [Related]

  • 17. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
    Bellows BK, Dahal A, Jiao T, Biskupiak J.
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):153-64. PubMed ID: 22509775
    [Abstract] [Full Text] [Related]

  • 18. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M.
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia.
    Rodríguez MJ, Díaz S, Vera-Llonch M, Dukes E, Rejas J.
    Curr Med Res Opin; 2007 Oct; 23(10):2585-96. PubMed ID: 17875242
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
    Wielage R, Bansal M, Wilson K, Klein R, Happich M.
    Spine (Phila Pa 1976); 2013 May 15; 38(11):936-46. PubMed ID: 23250234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.